Cite

HARVARD Citation

    Booth, J. et al. (2021). MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose. Radiotherapy and oncology. pp. 131-137. [Online]. 
  
Back to record